Clinical Trial

Effect of Mannitol on Propofol Level

Study acronym: level
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated October 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Group 1 will include 20 patients aged 18 years and over, American Society of Anesthesiologist (ASA) II-III class, who will undergo supratentorial tumor surgery, and Group 2 will include 20 patients who will undergo pituitary surgery without mannitol. Total intravenous anesthesia (TIVA) will be adjusted to propofol 4 µg/dl and remifentanil 2-4 µg/dl with target-controlled infusion pumps. In the mannitol group, 2.5 ml/kg (0.5 g/kg) will be given to all patients 20 minutes after induction and the mannitol infusion will be adjusted to be 10 minutes.In Group 2, mannitol will not be used and 2.5 ml/kg isotonic will be administered in 10 minutes. Both blood and urine samples will take for measurement to propofol levels.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-18.
Status change: Not Yet Recruiting → Recruiting 2025-08-25
Trial Details
NCT Number NCT06884657
Lead Sponsor Cukurova University
Conditions Mannitol Adverse Reaction
Enrollment 40 participants
Start Date 2025-03-20
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-02